RESULTS:
Of 70,339 patients identified as above, 9,931 had a complication associated with their procedure. mFI of 0.12 (±0.11) was calculated for these patients and was significantly greater than 0.077 (±0.85) for patients with no complications (p<0.001). When examining mFI correlation with Clavien-Dindo Grade IV complications (n=2,541), mFI once again was significantly greater (0.16 ± 0.12) than those with no Grade IV complications (0.080 ± 0.09; p<0.001). Multivariate analyses also showed that all individual factors of the mFI (diabetes mellitus, hx of MI, etc.) were predictive of any complications and Grade IV complications (p<0.001). Calculated odds ratios showed that higher pre-operative mFI also had a 7.77x likelihood of having any complication, 35.71x likelihood of having a Grade IV complication, 3.85x likelihood of having a surgical site complication, and a 62.05x likelihood of death (all p<0.001). Recursive partitioning revealed that a threshold of greater than 3 indicators of mFI conferred a 2.07x likelihood of a Grade IV complication and a 2.33x likelihood of death (both p<0.001).
DISCUSSION:
We have shown that frailty as measured by mFI is an accurate predictor of morbidity, complications, and mortality in patients undergoing CAWR. Additionally, we have determined a frailty threshold of complications and mortality rate for plastic surgeons to consider during patient selection. The purpose of this study is to look at the rate of conversion of primary breast reconstruction patients to receiving either non-invasive or surgical cosmetic procedures after reconstruction.
Impact of Breast Reconstruction

METHODS:
A retrospective review of primary breast reconstruction patients of the two senior authors was conducted from January 2014-December 2015. Information including types of cosmetic procedures received and time to first cosmetic procedure were obtained. Time to first cosmetic procedure was assessed from date of initial reconstructive surgery through December 2017.
RESULTS:
There were 289 primary breast reconstruction patients seen from January 2014-December 2015. A total of 30 (10.4%) patients underwent at least 1 cosmetic procedure after reconstructive surgery through December 2017. The average time to first cosmetic procedure was 8.61 months +/-6.47 after their initial reconstructive surgery. Majority of patients (20, 66.7%) underwent non-invasive cosmetic procedures only. Six (20%) patients underwent a surgical cosmetic procedure only and 4 (13.3%) patients underwent both noninvasive and surgical cosmetic procedures. For patients that underwent a surgical procedure they have thus far only undergone 1 surgery. For patients that had non-invasive cosmetic procedures, they averaged 4.96 procedures (range 1 to 22).
CONCLUSION:
While breast reconstruction after breast cancer is a common path that women take, some may seek cosmetic procedures to further improve their self-image. For our senior authors this resulted in an ~10% conversion rate over 4 years of primary breast reconstructive patients. On average patients underwent a procedure about 9 months after the initial reconstructive surgery. Majority of patients underwent non-invasive cosmetic procedures averaging about 5 treatments per patient. Surgical patients underwent 1 surgery each over the timeframe.
